Your Search Returned 1 tagged news report
Phase III clinical trial of its lung cancer drug Alimta showed a significant survival benefit in patients with advanced non-small cell lung cancer.
Tags: Eli Lilly and Co., lung cancer, cancer patients, Lilly Cancer Drug Shows, msn money, Alimta, phase iii, market reports, clinical trial, Indianapolis